Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-062114
Filing Date
2016-04-26
Accepted
2016-04-26 20:19:20
Documents
2
Period of Report
2016-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1697
2 poa_oneill.htm EX-24 7989
  Complete submission text file 0001140361-16-062114.txt   10998
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
O'Neill Vincent (Reporting) CIK: 0001672718 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 161593120